Announcements
Board of Directors approved the Company’s 2018 individual and consolidated financial statements
Date of occurrence of the event: Mar 8, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
Announcement of the resolution of the treasury shares and the establishment of the base date for capital reduction by board of directors
Date of the board of directors resolution: Mar 8, 2019 Reason for the capital reduction: The first-time purchase of the treasury shares are obsoleted as they have not been transferred …
Clearance of Adagloxad Simolenin (OBI-822) for a Phase III clinical study by Ministry of Health of Ukraine
Date of occurrence of the event: Feb 20, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
Clarification on the collaborative publication by OBI Pharma Inc. and Academia Sinica
Date of occurrence of the event: Feb 13, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
OBI Pharma Inc. to attend The 37th Annual J.P. Morgan Healthcare Conference
1.Date of the event: Jan 10, 2019 2.Time: 01:00:00 NST 3.Location: Westin St. Francis Hotel, San Francisco, California 4.Summary: OBI Pharma Inc. to attend The 37th Annual J.P. Morgan Healthcare …
Company Chairman Mr. Michael N. Chang not guilty for the prosecution by Taiwan Shilin District Court
Parties to the legal matter: OBI Chairman Dr. Michael N. Chang Name of the court or disposing agency: Taiwan Shilin District Court Reference/case numbers of relevant documents: Year 106, Zhu …
OBI Pharma Inc. to attend 2019 investor conference hosted by Yuanta
1.Date of the event: Dec 20, 20182.Time: 15:00:00 NST3.Location: The Westin Taipei4.Summary: OBI Pharma Inc. to attend 2019 investor conference hosted by Yuanta 5.Any other matters that need to be …
OBI Pharma Inc. to attend the Citi’s 2018 Global Healthcare Conference
1.Date of the event: Dec 5 ~ Dec 6, 2018 2.Time: 22:00:00 NST 3.Location: The Lotte New York Palace 4.Summary: OBI Pharma Inc. to attend the Citi’s Adhd Drugs Healthcare …
Announcement of the resolution of the board of directors of the company to issue common shares through rights offering
Date of the board of directors resolution: Nov 30, 2018 Source of capital increase funds: issue common shares through rights offering Number of shares issued: 15,000,000 common shares Par value …
OBI Pharma Inc. to attend the 2018 Asia Pacific Healthcare Forum, hosted by Goldman Sachs
1.Date of the event: Nov 27 ~ Nov 28, 2018 2.Time: 09:00:00 CST 3.Location: Jw Marriott Hotel Hong Kong Level 3 Ballroom 4.Summary: OBI Pharma Inc. to attend the 2018 …